Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 10 11 12 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Carbios S.A.. (8/9/22). "Press Release: WhiteCycle – a European Consortium to Recycle Plastic Waste". Clermont-Ferrand. 2022-08-09
Immatics N.V.. (8/9/22). "Press Release: Immatics Announces Second Quarter 2022 Financial Results and Business Update". Tübingen & Houston, TX. 2022-08-09
908 Devices, Inc.. (8/9/22). "Press Release: 908 Devices Acquires Trace Analytics, Enabling On-line Bioanalytics". Boston, MA. 2022-08-09
Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen. 2022-08-08
Evitria AG. (8/8/22). "Press Release: Genovis AB Enters Service Agreement with Evitria AG for Fast LC-MS Analysis of Recombinant Antibodies". 2022-08-08
Valneva S.E.. (8/8/22). "Press Release: Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15". New York, NY & Saint-Herblain. 2022-08-08
BioNTech SE. (8/8/22). "Press Release: BioNTech Announces Second Quarter Financial Results and Corporate Update". Mainz. 2022-08-08
BioNTech SE. (8/5/22). "Press Release: BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates". Mainz & Copenhagen. 2022-08-05
Amgen Inc.. (8/4/22). "Press Release: Amgen to Acquire ChemoCentryx for $4 Billion in Cash". Thousand Oaks, CA & San Carlos, CA. 2022-08-04
Sanofi S.A.. (8/4/22). "Press Release: Sanofi and Innovent Biologics Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China". Paris. 2022-08-04
Formycon AG. (8/3/22). "Press Release: U.S. Food and Drug Administration (FDA) Approved FYB201/Cimerli (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis". Munich, Amsterdam & Zug. 2022-08-03
Poseida Therapeutics, Inc.. (8/3/22). "Press Release: Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies". San Diego, CA. 2022-08-03
Quantro Therapeutics GmbH. (8/3/22). "Press Release: Quantro Therapeutics Collaborates with Boehringer Ingelheim to Develop Drug Candidates Interfering with Transcriptional Regulators". Vienna. 2022-08-03
ResMed Inc.. (8/2/22). "Press Release: ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio". Martinsried & Leipzig. 2022-08-02
NLC Ventures Netherlands B.V.. (8/2/22). "Press Release: Haermonics Series A Funding Offers Pure™ Promise for Future Heart Surgery Patients". Eindhoven. 2022-08-02
Biosynth Carbosynth. (8/2/22). "Press Release: Biosynth Carbosynth to Offer Enzyme Development Following Acquisition of Eucodis Bioscience". Staad. 2022-08-02
Agilent Technologies Inc.. (8/2/22). "Press Release: Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis". Santa Clara, CA. 2022-08-02
Eppendorf SE. (8/1/22). "Press Release: Eppendorf Opens New Site in Singapore". Singapore & Hamburg. 2022-08-01
Valneva S.E.. (8/1/22). "Press Release: Valneva Confirms Amendment of Advance Purchase Agreement with European Commission for Valneva’s Inactivated COVID-19 Vaccine". Saint-Herblain. 2022-08-01
Cleerly, Inc.. (7/28/22). "Press Release: Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million [updated version of press release from 25 July]". New York, NY. 2022-07-28
Scienion GmbH. (7/28/22). "Press Release: Scienion Announces Expansion in the UK with the Opening of New R&D and Manufacturing Facilities". Lakeside North Harbour, Portsmouth. 2022-07-28
Core Biogenesis SAS. (7/28/22). "Press Release: Core Biogenesis Raises $10.5M to Accelerate Plant-Based Bioproduction". Strasbourg. 2022-07-28
Ryvu Therapeutics S.A.. (7/26/22). "Press Release: Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board". Kraków. 2022-07-26
Precirix N.V.. (7/26/22). "Press Release: Precirix and Eckert & Ziegler Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225". Brussels & Berlin. 2022-07-26
NeoSphere Biotechnologies GmbH. (7/25/22). "Press Release: NeoSphere Biotechnologies Closes Financing Round to Expand Proteomics Platform for Systematic Identification of Novel Targets for Targeted Protein Degradation". Munich. 2022-07-25
Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities". Boston, MA. 2022-07-25
Dermagnostix GmbH. (7/22/22). "Press Release: Dermagnostix Closes Seed Plus Funding Round of €4.6 M". Friedberg/Freiburg. 2022-07-22
Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen. 2022-07-21
Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent ". Aubagne. 2022-07-21
Valneva S.E.. (7/20/22). "Press Release: European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine". Saint-Herblain. 2022-07-20
PBD Biotech Ltd.. (7/19/22). "Press Release: Mondana Cook Joins PBD Biotech to Bring Human TB Diagnostic to Market". 2022-07-19
Delfi Diagnostics, Inc.. (7/18/22). "Press Release: Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests". Baltimore, MD & Palo Alto, CA. 2022-07-18
Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel. 2022-07-18
Enterome S.A.. (7/18/22). "Press Release: Enterome Signs Major Strategic R&D Collaboration with Nestlé Health Science to Develop and Commercialize New AllerMimics and EndoMimics Immunotherapies for Food Allergies and Inflammatory Bowel Disease". Paris. 2022-07-18
SHS Gesellschaft für Beteiligungsmanagement mbH. (7/18/22). "Press Release: More than 220 Million Euros for Growth and Succession Investments in European Healthcare Companies". 2022-07-18
IZB Martinsried. (7/14/22). "Press Release: Cutting-edge Research at Munich’s IZB Attracts Strong Interest". Martinsried. 2022-07-14
Rubius Therapeutics, Inc.. (7/14/22). "Press Release: Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors". Cambridge, MA. 2022-07-14
Apertura Gene Therapy LLC. (7/14/22). "Press Release: Apertura Appoints Gene Therapy Executive Joseph La Barge as Chief Executive Officer". New York, NY & Cambridge, MA. 2022-07-14
Heidelberg Pharma AG. (7/13/22). "Press Release: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate (ad hoc)". Ladenburg. 2022-07-13
Mosanna Therapeutics AG. (7/13/22). "Press Release: Mosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS-118 to Treat Metabolic Obstructive Sleep Apnea". Basel. 2022-07-13
BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing. 2022-07-13
Corat Therapeutics GmbH. (7/13/22). "Press Release: € 38.7 Mio. German Government Funding for the Clinical Development of a Corona Medication". Braunschweig. 2022-07-13
Anjarium Biosciences AG. (7/12/22). "Press Release: Anjarium Biosciences Appoints Experienced Industry Executives Samantha Vieira as Chief Operating Officer and Nate Massari as Chief Business Officer". Zurich. 2022-07-12
Solvias AG. (7/12/22). "Press Release: Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities". 2022-07-12
Vaccentis AG. (7/12/22). "Press Release: Vaccentis Appoints Martin Munte as CEO and Strengthens Board". Zurich. 2022-07-12
Adrenomed AG. (7/12/22). "Press Release: Adrenomed Appoints David Germonpré as Chief Financial Officer". Zurich. 2022-07-12
Delfi Diagnostics, Inc.. (7/12/22). "Press Release: Jessica Meng Joins Delfi Diagnostics as Chief Commercial Officer". Baltimore, MD. 2022-07-12
Biosaxony. (7/12/22). "Pressemitteilung: Medical Forge Leipzig lässt die Funken fliegen". 2022-07-12
Gilde Healthcare Partners. (7/12/22). "Press Release: Gilde Healthcare Bolsters Its Private Equity Team in Frankfurt Office". Utrecht & Frankfurt a. M.. 2022-07-12
Bicycle Therapeutics plc. (7/12/22). "Press Release: Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration". Cambridge & Boston, MA. 2022-07-12
Glycomine, Inc.. (7/11/22). "Press Release: Glycomine Appoints Steven Axon as CEO and Adds Two New Board Directors". San Carlos, CA. 2022-07-11
4D Lifetec AG. (7/11/22). "Press Release: 4D Lifetec Announces Successful First closing of CHF 1.9 Million Series B Financing to Launch Its Early Lung Cancer Detection Liquid Biopsy Assay 4D Lifetest Lung Dx in Europe". Cham. 2022-07-11
ADC Therapeutics S.A.. (7/8/22). "Press Release: ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize Zynlonta (loncastuximab tesirine-lpyl) in Europe and Select International Territories". Lausanne. 2022-07-08
ECBF Management GmbH. (7/7/22). "Press Release: ECBF Expands Its Industrial Biotech Portfolio to Offer Naturally Produced Vitamins". Luxembourg. 2022-07-07
Evotec SE. (7/6/22). "Press Release: Evotec, Boehringer Ingelheim, and bioMérieux Launch Aurobac, a Joint Venture to Fight Antimicrobial Resistance". Germany & France. 2022-07-06
Immunic, Inc.. (7/6/22). "Press Release: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén". New York, NY. 2022-07-06
BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambridge, MA, Basel & Beijing. 2022-07-06
CureVac N.V.. (7/5/22). "Press Release: CureVac Files Patent Infringement Lawsuit in Germany against BioNTech". Tübingen & Boston, MA. 2022-07-05
Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA. 2022-07-05
Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel & 2022-07-05
Scienion GmbH. (7/5/22). "Press Release: Highfield Diagnostics and Scienion Sign Memorandum of Understanding". Southampton & Berlin. 2022-07-05
Evotec SE. (7/5/22). "Press Release: Evotec Completes Acquisition of Rigenerand". Hamburg. 2022-07-05
Evotec SE. (7/4/22). "Press Release: Evotec SE – Translational BRIDGE Partnership beLAB2122 Selects Oncology Project from Goethe University Frankfurt". Hamburg. 2022-07-04
ADC Therapeutics S.A.. (7/1/22). "Press Release: ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors". Lausanne. 2022-07-01
Symrise AG. (6/30/22). "Press Release: Symrise Cosmetic Ingredients Enters Strategic Partnership with Evoxx Technologies". Holzminden. 2022-06-30
Biosynth Carbosynth. (6/30/22). "Press Release: Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan". Staad. 2022-06-30
Leukocare AG. (6/30/22). "Press Release: Leukocare Announces New Management Structure to Support Global Set-up and Accelerate Growth". Martinsried. 2022-06-30
BIO Deutschland e. V.. (6/29/22). "Press Release: President of German Biotechnology Industry Association Elected Chairman of International Umbrella Organization". Berlin. 2022-06-29
ReCode Therapeutics. (6/29/22). "Press Release: ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M". Menlo Park, CA & Dallas, TX. 2022-06-29
Molzym GmbH & Co. KG. (6/29/22). "Press Release: Molzym Announces Double-Digit Million EUR Capital Increase". Bremen. 2022-06-29
ADC Therapeutics S.A.. (6/29/22). "Press Release: ADC Therapeutics Doses First Patient in Phase 1b Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) in Combination with Other Anti-cancer Agents". Lausanne. 2022-06-29
mk2 Biotechnologies GmbH. (6/28/22). "Press Release: mk2 Biotechnologies and Sartorius Stedim Biotech Join Forces to Develop a Biologics Production Platform". 2022-06-28
Wacker Chemie AG. (6/2/22). "Press Release: Wacker to Invest Double-Digit Million-Euro Sum in Biotechnology Center". Munich. 2022-06-27
VI Partners. (6/27/22). "Press Release: VI Partners Welcomes Simon Meier as Partner, Healthcare". 2022-06-27
Centogene N.V.. (6/27/22). "Press Release: Centogene Announces Appointment of Miguel Coego Rios as Chief Financial Officer". Cambridge, MA, Rostock & Berlin. 2022-06-27
Verve Capital Partners AG (Verve Ventures). (6/24/22). "Press Release: Verve Ventures Launches Investment Fund to Support Portfolio Companies". 2022-06-24
Valneva S.E.. (6/24/22). "Press Release: Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001". Saint-Herblain. 2022-06-24
Merck KGaA. (6/23/22). "Press Release: Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies". Darmstadt. 2022-06-23
F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London. 2022-06-23
Valneva S.E.. (6/23/22). "Press Release: Valneva and Pfizer Announce Closing of Equity Investment". Saint-Herblain & New York, NY. 2022-06-23
Ningaloo Biosystems GmbH. (6/22/22). "Press Release: Ningaloo’s Opto-Bioproduction Platform Gets Boost from Investors". Cologne. 2022-06-22
Tolremo Therapeutics AG. (6/22/22). "Press Release: Tolremo Therapeutics AG Announces Appointment of Dr. Karl Schumacher as Chief Medical Officer". Muttenz. 2022-06-22
Ascenion GmbH. (6/21/22). "Press Release: Carma Fund I Completes First Closing of EUR 47 Million to Accelerate the Transfer of Life-Science Research into Practice". Munich & Frankfurt a. M.. 2022-06-21
Knauer Wissenschaftliche Geräte GmbH. (6/21/22). "Press Release: Knauer Wissenschaftliche Geräte Is Partnering with ModuVision". 2022-06-21
Precision BioSciences, Inc.. (6/21/22). "Press Release: Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease". Durham, NC. 2022-06-21
Kranus Health GmbH. (6/20/22). "Press Release: Kranus Health Closes Series A Financing and Has Now Raised a Total of 8 Million USD for Digital Men's Health". Berlin & München. 2022-06-20
Valneva S.E.. (6/20/22). "Press Release: Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15". Saint-Herblain & New York, NY. 2022-06-20
Hong Kong Science and Technology Parks (HKSTP). (6/17/22). "Press Release: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology". Hong Kong. 2022-06-17
Atai Life Sciences N.V.. (6/17/22). "Press Release: Stephen Bardin to Join Atai Life Sciences as CFO Designate". New York, NY & Berlin. 2022-06-17
Ymmunobio AG. (6/16/22). "Press Release: Ymmunobio Signs Collaboration Agreement with Yumab". Riehen. 2022-06-16
HH2E AG. (6/15/22). "Press Release: HH2E and MET Group Establish a Joint Project Company to Develop One of Europe’s Largest Green Hydrogen Production Plants in Lubmin, Germany". 2022-06-15
Gimv. (6/15/22). "Press Release: Gimv Strengthens Its Position in Life Sciences Venture Capital with the Creation of a New Dedicated Platform". Antwerp. 2022-06-15
Anjarium Biosciences AG. (6/14/22). "Press Release: Anjarium Biosciences Appoints Stephen Yoo, MD as Chief Executive Officer". Schlieren. 2022-06-14
Evotec SE. (6/14/22). "Press Release: Evotec Enters a Drug Discovery Collaboration with Janssen". Hamburg. 2022-06-14
MorphoSys AG. (6/14/22). "Press Release: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210". Planegg & South San Francisco, CA. 2022-06-14
Proscia Inc.. (6/14/22). "Press Release: Proscia Raises $37M Series C To Fulfill The Promise Of Precision Medicine With AI-Enabled Pathology". Philadeliphia, PA. 2022-06-14
ADC Therapeutics S.A.. (6/13/22). "Press Release: ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer". Lausanne. 2022-06-13
ImCheck Therapeutics SAS. (6/13/22). "Press Release: ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunothe 2022-06-13
Pepperprint GmbH. (6/9/22). "Press Release: Pepperprint GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity". Heidelberg. 2022-06-09
Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. 2022-06-09
next pagenext page 1 2 3 ... 10 11 12 ... 35 36 37  next pagenext page



Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top